Exchange: HEL Sector: Healthcare Industry: Biotechnology
-5.12% €2.04
America/New_York / 2 mai 2024 @ 11:29
FUNDAMENTALS | |
---|---|
MarketCap: | 174.31 mill |
EPS: | -0.260 |
P/E: | -7.85 |
Earnings Date: | May 30, 2024 |
SharesOutstanding: | 85.45 mill |
Avg Daily Volume: | 0.0664 mill |
RATING 2024-05-02 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -7.85 | sector: PE 13.91 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -7.85 | industry: PE -1.961 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
€ 1.874 - 2.21 ( +/- 8.14%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | €2.04 (-5.12% ) |
Volume | 0.0440 mill |
Avg. Vol. | 0.0664 mill |
% of Avg. Vol | 66.26 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.